News archive
![](https://amr-accelerator.eu/wp-content/uploads/2020/09/Circle_TricTB.png)
![](https://amr-accelerator.eu/wp-content/uploads/2021/12/ERA4TB_News_5000x4000px.png)
![](https://amr-accelerator.eu/wp-content/uploads/2021/12/ERA4TB_News_5000x4000px.png)
25/01/24 – Public launch of TB-Platform for the Aggregation of Preclinical Experiments Data (TB-APEX)
![](https://amr-accelerator.eu/wp-content/uploads/2022/06/GNA-NOW-5000-×-4000px.png)
23/01/24 – GNA NOW consortium expands its scope to support the under-studied condition of severe diarrhoea
![](https://amr-accelerator.eu/wp-content/uploads/2021/12/ERA4TB_News_5000x4000px.png)
![](https://amr-accelerator.eu/wp-content/uploads/2021/12/TRiC_TB_News_5000x4000px.png)
12/12/23 – BioVersys receives U.S. FDA orphan-drug designation for alpibectir and ethionamide fixed-dose combination for treatment of tuberculosis
![](https://amr-accelerator.eu/wp-content/uploads/2021/12/PRIMAVERA_News_5000x4000px.png)
24/11/23 – PrIMAVeRa provides in-depth reports on current evidence base of burden of AMR in Europe
![](https://amr-accelerator.eu/wp-content/uploads/2021/12/PRIMAVERA_News_5000x4000px.png)
24/11/23 – PrIMAVeRa 2nd annual meeting successfully held in hybrid format in Utrecht on 15-16 November 2023
![](https://amr-accelerator.eu/wp-content/uploads/2021/12/UNITE4TB_News_5000x4000px.png)
![](https://amr-accelerator.eu/wp-content/uploads/2023/11/AMR-Accelerator_square-3-e1716812644571.png)
![](https://amr-accelerator.eu/wp-content/uploads/2021/12/UNITE4TB_News_5000x4000px.png)
08/11/23 – A new dawn in the fight against Tuberculosis: UNITE4TB announces start of clinical trials
![](https://amr-accelerator.eu/wp-content/uploads/2021/12/ERA4TB_News_5000x4000px.png)